Labcompliance On-line Audio Seminar
This seminar has been recorded and is
available on CD and for instant download. All reference material as
listed below and more is available on a special seminar website. The
website is regularly updated with most recent information. In case
there are questions related to the topic, they can be submitted
through a web form and will be answered by the speaker. For ordering
info
click here.
On-line Audio Seminar 225
Six Steps
to Successful FDA GMP Inspections
With Tool Kits for
Preparation, Conduct and Follow-up
Recorded

An FDA inspection can be a business disaster that costs your
company money, time and reputation, or it can be an opportunity to make a long
lasting good impression at the FDA and to improve your quality systems.
Single and multiple 483 Inspectional Observations and Warning Letters can be a
disaster for a company. Bad reputation for the company and employees, delay of
new product approvals, import alters, products recalls, multi-million $ fees,
seizures and consent degrees can be the consequence if not followed up correctly
in time. However, 483's and warning letters can be avoided.
Knowing FDA regulations and guidelines help but are not enough. Knowing what FDA
inspectors are looking at and knowing enforcement practices and trends are
equally important. And when it happened, damage can be minimized by effective
and timely response.
Key Questions related to FDA Inspections are:
- What is FDA's system inspection process?
- Which GMP systems are always inspected?
- What are inspectors looking at within the
systems?
- What are most common deviations?
- How to prepare our staff for an
inspection?
- How to treat an inspector?
- What to do if I don't agree with the
inspector's observations?
- What documents should be available and
what can/should we give or not give to the inspector?
- How can I avoid 483's and Warning
Letters: during the inspection, in the exit meeting, afterwards?
- How to follow up on 483s and warning
letters
How does the audio seminar help:
Answers will be presented by Dr. Ludwig Huber
in a new interactive audio seminar. During the seminar, the speaker
will present strategies and give practical recommendations. After
the seminar, an extensive list of reference material like SOPs,
templates and examples will help immediate and cost effective
implementation.
During the interactive presentation you learn
about:
- Six steps steps to successfully surviving
FDA inspections
- Inspection process for API and drug
manufacturing
- Current inspection and enforcement
practices
- Writing an SOP for inspections
- Preparing your staff for an FDA
inspection
- Conducting internal audits in preparation
for FDA inspections
- Required documents and the right format
- How to treat the inspector
- Understand what the inspector is most
interested to look at and why
- What to say and what not say during
inspections
- The right response to observations
during inspections
- Responding to 483's and warning letters
- Current most common inspection findings
And for easy and instant implementation:
download 10+ documents from special seminar website
- FDA Inspection Survival Guide: 80 page
document everybody should be aware of
- SOPs:
- FDA inspections - preparation, conduct, follow up
- Internal audits - The idea preparation for FDA inspections
- Gap analysis/check lists
- FDA Inspections: preparation, conduct, follow-up
- Good Manufacturing practices
- More than 200 examples of FDA GMP
483s/Warning Letters/EIRs
With keyword search and instant download
- FDA Presentations - Leaning from the
inspectors
- Insight on FDA Inspections and Recommendations
- The Inspection is Over – What Happens Next? Possible FDA
Enforcement Actions
- Writing An Effective 483 Response
- FDA API Inspections
- FDA cGMP Inspections
- FDA Update: Data Integrity and Fraud – Another Looming Crisis?
- Laboratory GMPs and Inspectional Issues: an FDA Perspective
- FDA Guides
- Foreign inspection guide
- Inspection of pharmaceutical QC labs
- Drug manufacturing inspections guide
- FDA Inspections of Clinical Investigators
- And more....
Who should attend?
- QA managers and personnel
- Analysts and lab managers
- Validation specialists
- Regulatory affairs
- Training department
- Documentation department
- Consultants
Date, time and duration
Order at any time, replay at any time.
How to order
Pick one of the options in the table that fits your needs.
|
Recorded seminar -
Web Download
- Multiple persons - single site
- Learn at your desk, meet in a seminar or conference
room or share the audio file and reference material at your site.
- Order includes all reference material.
|
US$ 399.-

|
|
Recorded seminar -
CD
- Get the CD in your mail
- Order includes all reference material.
|
US$ 399.-

|
|
Special offer for
Labcompliance Usersclub Members
Recorded Seminar- CD or Web download.
- Order includes all reference material.
- for Usersclub information and registration,
click here
|
US$ 299.-

|
About audio seminars

Online audio seminars are
presented over the phone. During the live presentation attendees
can:
- Study the printed slide material
- Watch the slides on a computer
- Watch the slides on a video screen in a
seminar room
- Ask questions through email and web form
About Dr. Ludwig Huber
Dr. Ludwig Huber is the author of the Labcompliance
Newsletter. He has been conducting over 100 web and audio or video based
seminars since ten years. He is worldwide director for FDA compliance at Agilent
Technologies.
|
Dr. Ludwig Huber is a frequent presenter
at IVT conferences and has been awarded as the 'Presenter of
the Year' out of 170 speakers. This photo is from IVT's
conference on Network Qualification with Ludwig Huber as
plenary speaker. |
Dr. Huber has published several books related
to validation and compliance, for example: Validation of
Computerized Analytical and Networked Systems. He was or still is a
member of several committees, e.g., of the GAMP Special interest
group (SIG) on Laboratory Computers, PDA Part 11 task force, IVT
task force on network infrastructure qualification and the European
Compliance Academy. He frequently visits FDA in Rockville, VA, and
participates in panel discussions with FDA professionals. For more
information,
click here.